Grun D, Adhikary G, Eckert R. NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival. Mol Carcinog. 2018;: pubmed publisher

Zanotto Filho A, Rajamanickam S, Loranc E, Masamsetti V, Gorthi A, Romero J, et al. Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer Lett. 2018;425:101-115 pubmed publisher

Liu J, Jin X, LIU K, Liu W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. J Neurosci. 2012;32:3044-57 pubmed publisher

Shih Y, Takada Y, Lo S. Silencing of DLC1 upregulates PAI-1 expression and reduces migration in normal prostate cells. Mol Cancer Res. 2012;10:34-9 pubmed publisher

Jia H, Cheng L, Tickner M, Bagherzadeh A, Selwood D, Zachary I. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br J Cancer. 2010;102:541-52 pubmed publisher